ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Jul 29, 2021 17:34 JST
Source:
Eisai
Eisai Listed for 20th Consecutive Year in FTSE4Good Index Series, An Index for Socially Responsible Investment
TOKYO, Jul 29, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has been included in the FTSE4Good Index Series for the 20th consecutive year since its initial inclusion in 2002. The FTSE4Good Index Series is a global index series for socially responsible investment.
The FTSE4Good Index Series is designed to help investors integrate the global standard factors of environmental, social and governance (ESG) into their investment decisions. Eisai received particularly high scores in "Corporate Governance", "Human Rights & Community", "Labor Standards", and "Anti-Corruption", among others. As of the end of June 2021, a total of 1,045 companies from around the world have been selected for the FTSE4Good Developed Index, including 204 companies from Japan.
Along with being listed in the FTSE4Good Index Series, Eisai is also listed in the MSCI Japan Empowering Women Index (WIN), the FTSE Blossom Japan Index, the MSCI Japan ESG Select Leaders Index, and S&P/JPX Carbon Efficient Index, which are the four ESG investment indices for Japanese stocks adopted by the Government Pension Investment Fund (GPIF).
Eisai's corporate philosophy is to give first thought to patients and their families, and increase the benefits that health care provides as well as address diverse healthcare needs worldwide. By strengthening its ESG initiatives and increasing non-financial value, Eisai is striving to sustainably enhance corporate value based on this corporate philosophy.
Media Inquiries:
Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120
Source: Eisai
Sectors: BioTech
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Hydrogen-powered Engine Corolla Takes on the Challenge of Transporting Imported Hydrogen at Super Taikyu Series 2021 Suzuka S-tai
Sep 20, 2021 09:03 JST
Honda Exhibits the World Premiere of All-new BF150, BF135 and BF115 Large-size Marine Outboard Engines at the Genoa International Boat Show 2021
Sep 16, 2021 19:08 JST
Applus+ IDIADA and MHI Group to Develop Testing and Verification System for Highly Automated Vehicles
Sep 16, 2021 14:52 JST
Honda: Takahisa Fujinami to End 26-Year Trial World Championship Career
Sep 15, 2021 19:30 JST
NEC Utilizes Digital Technologies to Create Healthcare and Life Science Business
Sep 15, 2021 09:59 JST
Eisai to Join The Global Environmental Initiative "RE100"
Sep 14, 2021 17:46 JST
Telefonica and NEC to Build Open RAN Live Pilots in 4 Global Markets as a Key Milestone Toward Mass Deployment
Sep 14, 2021 17:03 JST
Toyota to Launch All-New Corolla Cross
Sep 14, 2021 14:05 JST
Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2021
Sep 14, 2021 12:36 JST
Lucid and Cross Marketing Co. Ltd. partner on 'Global QiQUMO'
Sep 14, 2021 09:00 JST
Showa Denko Concludes Long-Term Contract to Supply SiC Epitaxial Wafers for ROHM Co., Ltd.
Sep 13, 2021 17:00 JST
AbbVie, Eisai, and EA Pharma Launch "Humira Support Tool Ordering Service for Patients"
Sep 13, 2021 16:37 JST
Epic Triumph for Rovanpera and the Toyota Yaris WRC in Greece
Sep 13, 2021 14:34 JST
Mitsubishi Heavy Industries and Osaka Gas Acquire Clean Energy Solution, Brighter Future Solar Project
Sep 13, 2021 13:04 JST
Hitachi Sets New Target to Contribute to a Net Zero Society
Sep 13, 2021 11:41 JST
Tech Leaders from The Philippines to Draw Insights From Use-Cases and Informative Keynotes at Trescon's World AI & RPA Show
Sep 11, 2021 09:00 JST
MHI Thermal Systems' Air Conditioners for the Australian Market Receive Highest Ratings Once Again
Sep 10, 2021 13:02 JST
Chevron Agrees on Framework to Join Hydrogen Joint Venture with Magnum Development and Mitsubishi Power
Sep 10, 2021 11:15 JST
Hitachi Elevator Philippines Receives 67 Elevators and Escalators Order for Its First Railway System Project
Sep 09, 2021 13:57 JST
Mitsubishi Corporation and Shell Sign MoU to Collaborate on Hydrogen Plans in Alberta
Sep 09, 2021 12:36 JST
More Latest Release >>
Related Release
Eisai to Join The Global Environmental Initiative "RE100"
September 14 2021 16:46 JST
Eisai to Present Abstracts on Oncology Products and Pipeline at ESMO Virtual Congress 2021
September 14 2021 11:36 JST
AbbVie, Eisai, and EA Pharma Launch "Humira Support Tool Ordering Service for Patients"
September 13 2021 15:37 JST
Eisai and FUJI YAKUHIN Conclude License Agreement Concerning the Development and Distribution of Dotinurad in Five ASEAN Countries
August 31 2021 08:42 JST
Anticancer Agent "Tazverik Tablets 200mg" (Tazemetostat Hydrobromide) Launched in Japan for EZH2 Gene Mutation-Positive Follicular Lymphoma
August 16 2021 09:07 JST
FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for First-Line Treatment of Adult Patients with Advanced Renal Cell Carcinoma (RCC)
August 12 2021 08:31 JST
Eisai Receives Award for Excellence in Corporate Communications at the 37th Corporate Communications Awards
August 05 2021 10:45 JST
Eisai's Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures
August 02 2021 11:24 JST
Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)
July 30 2021 09:07 JST
Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer's Disease at AAIC 2021
July 30 2021 08:24 JST
More Press release >>